Item 9 Labs Corp.
INLB · OTC
9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Market Cap | $38 | $125 | $92 | $172 |
| - Cash | $0 | $1 | $0 | $0 |
| + Debt | $28 | $21 | $8 | $5 |
| Enterprise Value | $66 | $144 | $100 | $176 |
| Revenue | $22 | $22 | $8 | $5 |
| % Growth | -0.8% | 170.1% | 64.6% | – |
| Gross Profit | $7 | $9 | $3 | $2 |
| % Margin | 33.6% | 39.3% | 40.6% | 48.2% |
| EBITDA | -$23 | -$4 | -$4 | -$9 |
| % Margin | -104.9% | -19.8% | -54.8% | -181% |
| Net Income | -$31 | -$11 | -$12 | -$11 |
| % Margin | -143.1% | -49.7% | -151.4% | -215.5% |
| EPS Diluted | -0.33 | -0.14 | -0.2 | -0.17 |
| % Growth | -135.7% | 30% | -17.6% | – |
| Operating Cash Flow | -$2 | -$6 | -$1 | -$2 |
| Capital Expenditures | -$5 | -$2 | -$0 | -$6 |
| Free Cash Flow | -$8 | -$8 | -$2 | -$9 |